Loading clinical trials...
Loading clinical trials...
A Phase 2 Investigator Initiated Study to Determine the Efficacy and Safety of TVB- 2640 in Combination With Bevacizumab in Patients With First Relapse of High Grade Astrocytoma
Conditions
Interventions
Bevacizumab
TVB-2640
Locations
1
United States
University of Texas Health Science Center San Antonio at the Cancer Therapy and Research Center
San Antonio, Texas, United States
Start Date
May 18, 2017
Primary Completion Date
April 4, 2020
Completion Date
April 5, 2021
Last Updated
June 15, 2023
NCT04065776
NCT02800486
NCT05789394
NCT07417761
NCT06809322
NCT06860594
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions